| Followers | 9889 |
| Posts | 261364 |
| Boards Moderated | 4 |
| Alias Born | 12/27/2006 |
Monday, March 02, 2020 5:33:48 PM
* * $KPTI Video Chart 03-02-2020 * *
Link to Video - click here to watch the technical chart video
Link to Video - click here to watch the technical chart video
Recent KPTI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 08:03:38 PM
- Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual Meeting • PR Newswire (US) • 04/21/2026 02:32:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/13/2026 12:25:35 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/13/2026 12:23:13 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/02/2026 08:26:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 12:04:27 PM
- Karyopharm shares rise 10% after mixed Phase 3 SENTRY trial results • IH Market News • 03/24/2026 12:52:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 12:00:37 PM
- Karyopharm Announces $30 Million Private Placement with RA Capital • PR Newswire (US) • 03/24/2026 11:01:00 AM
- Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction • PR Newswire (US) • 03/24/2026 11:00:00 AM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/02/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:06:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 09:02:12 PM
- Registration Momentum Builds Across the Oncology Pipeline • GlobeNewswire Inc. • 02/17/2026 03:48:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 12:32:06 PM
- Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress • PR Newswire (US) • 02/12/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:11:58 PM
- Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 • PR Newswire (US) • 02/05/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:11:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:32:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:31:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:29:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:28:17 PM
